Related Experiment Video
Updated: Dec 5, 2025
09:02
Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
24.0K
Flavonoids targeting NRF2 in neurodegenerative disorders
Haroon Khan1, Rosa Tundis2, Hammad Ullah1
1Department of Pharmacy, Abdul Wali Khan University Mardan, 23200, Pakistan.
Summary
Flavonoids, natural compounds, show neuroprotective effects by regulating the Nrf2 pathway. This review explores their potential in preventing and treating neurodegenerative disorders like Alzheimer's and Parkinson's.
Area of Science:
- Neuroscience
- Pharmacology
- Natural Products Chemistry
Background:
- Neurodegenerative disorders involve progressive neuron loss with no effective cures, only symptomatic treatments.
- Natural compounds, particularly flavonoids, exhibit neuroprotective properties against conditions like Alzheimer's and Parkinson's disease.
- The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway is crucial for cellular protection against various chronic conditions.
Purpose of the Study:
- To review the contemporary information on Nrf2 pathway regulation by flavonoids.
- To explore the potential of flavonoids in preventing and treating neurodegenerative disorders.
- To highlight the therapeutic promise of natural compounds targeting the Nrf2 pathway.
Main Methods:
- Literature review of scientific articles and research papers.
- Analysis of studies investigating flavonoid mechanisms of action.
- Focus on research related to Nrf2 pathway activation by flavonoids in neurological contexts.
Main Results:
- Flavonoids are identified as key regulators of the Nrf2 pathway.
- Evidence suggests flavonoids can mitigate neuronal damage in various neurodegenerative models.
- Nrf2 activation by flavonoids offers a promising therapeutic strategy for neuroprotection.
Conclusions:
- Flavonoids represent a significant class of natural compounds with therapeutic potential for neurodegenerative diseases.
- Targeting the Nrf2 pathway with flavonoids offers a promising avenue for developing novel neuroprotective strategies.
- Further research into flavonoid-Nrf2 interactions could lead to effective treatments for debilitating neurological conditions.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
9.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.3K
01:46Electron Transport Chain: Complex I and II
17.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.5K
01:22Alzheimer's Disease: Treatment
630
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
630
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
399
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
399
02:59Cancer Prevention
7.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.5K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
667
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
667